Chiropractic Spinal Manipulative Therapy for Acute Neck Pain

University Hospital, Akershus320 enrolled

Overview

Acute neck is very common in the general population and often causes disability over shorter or longer time periods. Unfortunately, the efficacy of chiropractic spinal manipulative therapy (CSMT) and the efficacy of Non-steroidal Anti-inflammatory Drugs (NSAIDs) on acute neck pain is unknown. This 4-arm randomized controlled trial (RCT) will likely provide evidence for the efficacy of CSMT as well as NSAIDs. The applied methodology of the study will aim towards the highest research standards possible for manual-therapy RCTs, thus avoiding typical methodological shortcomings from previous manual-therapy studies. Our aim is to establish evidence-based knowledge on the efficacy of CSMT and NSAIDs in the treatment of acute neck pain.

The Global Burden of Disease study ranks musculoskeletal neck pain as the most common disability worldwide. This study will highlight and validate CSMT for acute neck pain, compared to sham manipulation, ibuprofen and placebo medication. NSAIDs are the most frequently prescribed medications by GPs worldwide and are widely used for patients with back pain. However, evidence-based data are missing for acute neck pain patients treated with NSAIDs while existing evidence for CSMT for acute neck pain are limited by serious methodological shortcomings. The 4-arm placebo-controlled RCT will assess the efficacy in the following four treatment groups: 1. Chiropractic spinal manipulative therapy (CSMT) 2. CSMT sham manipulation (placebo) 3. Ibuprofen (NSAID) 4. Placebo medication We intend to invite 40 recruiting chiropractors from larger Norwegian cities, distributed by gender and geography. The study participants presenting to each chiropractor will be block-randomized equally into one of four study groups based on a computer-generated algorithm. Each chiropractor will include 16 participants, four into each arm. A total of 320 participants will be enrolled in the RCT, within 12 months. Participants randomized into the chiropractic treatment groups will receive 5 interventions over 12 days, i.e., CSMT or CSMT sham manipulation; while the pharmacological groups will receive 600mg ibuprofen or placebo administered 3 times daily for 12 days.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

Eligibility

Sex: ALLMin age: 18 YearsMax age: 59 Years

Medical Language ↔ Plain English

Inclusion criteria 1. Eligible participants are between the age of 18 and 59 years old 2. Acute non-radicular neck pain, i.e., grade 1 or 2 according to the classification by the Bone and Joint Decade 2000-2010 Task Force on neck pain 3. Onset of the present episode ≤2 weeks prior to the 1st chiropractic visit 4. Moderate, severe or very severe pain intensity, i.e., ≥4, on a numeric rating scale (NRS) 0-10 5. Pain free for at least four consecutive weeks prior to the present pain episode 6. Not treated by a chiropractor during the past 3 months 7. Participants must accept not to seek other manual and/or pharmacological treatments for their acute neck pain during the intervention period 8. Non-pregnant women. Women in doubt shall have a negative fertility test before inclusion Exclusion criteria 1. Contraindication to ibuprofen 1. active peptic ulcer 2. gastrointestinal bleeding 3. previous repeated episode (≥2 detected events) with peptic ulcer or gastrointestinal bleeding 4. previous gastrointestinal bleeding or ulcer using NSAIDs 5. hypersensitivity to ibuprofen 6. asthma induced by acetylsalicylic acid or other NSAIDs 7. urticarial 8. rhinitis 9. severe heart failure (NYHA class IV) 10. renal failure (glomerulus infusion \<30 ml/min) 2. Taken pain- and/or anti-inflammatory medicine during the past 24 hours? (Patients that have taken acute pain- and/or anti-inflammatory medicine, including ibuprofen, can be included if they come back after 24 hours without having taken the medicine where they then fill out questionnaires and are randomized at the clinic) 3. On prescribed antidepressant 4. Major psychiatric disorder 5. Pregnancy or intention to be pregnant 6. Contraindication to SMT 7. Signs of spinal radiculopathy including progressive neurological deficit 8. Upper cervical spine instability (positive Sharp-Purser test) 9. Previous fracture in the cervical and/or thoracic spine 10. Previous cervical spine surgery 11. Recent (\<6 months) severe physical trauma to the head, neck or thoracic spine within the previous 6 months 12. Concomitant low back pain with moderate, severe or very severe pain intensity (≥4 on a NRS) 13. Current chronic pain (defined as ≥3 months duration) 14. Rheumatoid arthritis 15. Recent (\<2 weeks) acute respiratory infection with fever 16. Any presence of ischemic symptoms upon examination 17. Horner's syndrome 18. Medical history of arterial anomalies 19. History of connective tissue disorder 20. Familial history of cervical artery dissection 21. Other vascular disorders 22. Inability to understand instructions given in the Norwegian language 23. Inability to fill out digital questionnaires 24. Other reasons to exclude the patient as deemed necessary by the chiropractor

Outcomes

Primary Outcomes

Mean pain intensity change

Numerical Rating Scale (NRS) 0-10

Time frame: From Day-0 to Day-14 between CSMT and sham CSMT, CSMT and ibuprofen, and CSMT and placebo medicine.

Secondary Outcomes

Mean pain intensity change

Numerical Rating Scale (NRS) 0-10

Time frame: From Day-0 to Day-14. Comparison between ibuprofen and placebo medicine.

Mean pain intensity change

Numerical Rating Scale (NRS) 0-10

Time frame: From Day-0 to Day 2-13 in the treatment period, and from Day-0 to Day 7, 28, 56, 84 and 168 post-treatment, respectively, and comparison between CSMT and sham CSMT, CSMT and ibuprofen, CSMT and placebo medicine, ibuprofen and placebo medicine.

Mean duration (hours) of neck pain change

Hours (0-24)

Time frame: From Day-0 to Day 2-13 and 14; From Day-0 to Day 7, 28, 56, 84 and 168 post-treatment, respectively, and comparison between CSMT and sham CSMT, CSMT and ibuprofen, CSMT and placebo medicine, ibuprofen and placebo medicine.

Mean number of days with neck pain per week

Weekly number of days

Time frame: From the treatment period (14 days) to the periods; day 1-7, 22-28, 50-56, 78-84 and 162-168 post-treatment, respectively, and comparison between CSMT and sham CSMT, CSMT and ibuprofen, CSMT and placebo medicine, ibuprofen and placebo medicine.

Proportions of participants with mean daily pain intensity reduction of ≥50%, ≥75% and 100%

Numerical Rating Scale (NRS) 0-10

Time frame: From Day-0 to Day 2-13 and 14, and from Day-0 to Day 7, 28, 56, 84 and 168 post-treatment, respectively, and comparison between CSMT and sham CSMT, CSMT and ibuprofen, CSMT and placebo medicine, ibuprofen and placebo medicine.

Proportions of participants with mean duration (hours) reduction of ≥50%, ≥75% and 100%

Hours 0-24

Proportions of participants with mean reduction of number of days with neck pain per week of ≥50%, ≥75% and 100%

Weekly number of days

Time frame: From the treatment period (14 days), to the periods: Day 1-7, 22-28, 50-56, 78-84 and 162-168 post-treatment, respectively, and comparison between CSMT and sham CSMT, CSMT and ibuprofen, CSMT and placebo medicine, ibuprofen and placebo medicine

Improvement in Research and development 12 (RAND-12) score (12 questions each with 5 possible answers)

RAND-12 Term Short Form Health Survey (0 to 100, with higher scores indicating better physical and mental health functioning)

Time frame: From Day-0 to Day-14, Day-84 and 168 post-treatment, respectively, comparison between CSMT and sham CSMT, CSMT and ibuprofen, CSMT and placebo medicine, ibuprofen and placebo medicine.

Improvement in Neck Disability Index score (10 questions each with 6 possible answers)

Neck Disability Index (0-100, where 0 = no disability and 100 = complete disability)

Time frame: From Day-0 to Day-14, Day-84 and 168 post-treatment, respectively, comparison between CSMT and sham CSMT, CSMT and ibuprofen, CSMT and placebo medicine, ibuprofen and placebo medicine.

Adverse event (AE) analysis

Within and between group adverse events analysis

Time frame: Daily during intervention period (day 2-13). AE analysis of CSMT, sham CSMT, ibuprofen, and placebo medicine, and comparison between CSMT and sham CSMT, CSMT and ibuprofen, CSMT and placebo medicine, ibuprofen and placebo medicine.

Analysis of patients' blinding (Manual therapy)

Numerical rating scale (NRS) 0-10 in relation to receiving real CSMT (0 absolutely unsure and 10 absolutely sure that real CSMT was received), irrespective of whether the patient received sham or real CSMT

Time frame: Daily during intervention period (Day-0, Day 2-13). Analysis of CSMT and sham CSMT, and comparison between CSMT and sham CSMT.

Analysis of patients' blinding (Medicine)

Numerical rating scale (NRS) 0-10 in relation to receiving ibuprofen (0 absolutely unsure and 10 absolutely sure that ibuprofen was received), irrespective of whether the patient received ibuprofen or placebo medicine

Time frame: Daily during intervention period (Day-0, Day 2-13). Analysis of ibuprofen and placebo medicine, and comparison between ibuprofen and placebo medicine.

Patients' and chiropractors' expectations to treatment efficacy

Numerical rating scale (NRS) 0-10 (0 no expectation at all and 10 the highest possible expectation to treatment efficacy)

Time frame: Day-0

Analysis of patients' satisfaction to treatment efficacy

Numerical rating scale (NRS) 0-10 (0 no satisfaction at all, and 10 the highest possible satisfaction)

Time frame: Day-14 of the intervention period

Chiropractic Spinal Manipulative Therapy for Acute Neck Pain

Overview

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Secondary Outcomes

Central Contacts